相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formation in Vitro
Hasnawati Saleh et al.
ENDOCRINOLOGY (2011)
IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF-α-Mediated Bone Loss
Mario M. Zaiss et al.
JOURNAL OF IMMUNOLOGY (2011)
Treatment Strategies and Clinical Trial Design in ADPKD
Vicente E. Torres
ADVANCES IN CHRONIC KIDNEY DISEASE (2010)
CRP Polymorphisms and Progression of Chronic Kidney Disease in African Americans
Adriana M. Hung et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus
Mo Yin Mok et al.
RHEUMATOLOGY (2010)
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
Vardit Lavi-Moshayoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Potential Role of Soluble ST2 Protein in Idiopathic Nephrotic Syndrome Recurrence Following Kidney Transplantation
Sarah Bruneau et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Inhibition of Interleukin-33 Signaling Attenuates the Severity of Experimental Arthritis
Gaby Palmer et al.
ARTHRITIS AND RHEUMATISM (2009)
被撤回的出版物: The cytokine interleukin-33 mediates anaphylactic shock (Retracted article. See vol. 109, pg. 15527, 2012)
Peter N. Pushparaj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cytokine dysregulation in chronic kidney disease: How can we treat it?
Juan Jesus Carrero et al.
BLOOD PURIFICATION (2008)
Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure
Thomas Mueller et al.
CLINICAL CHEMISTRY (2008)
Aspects of immune dysfunction in end-stage renal disease
Sawako Kato et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis
Damian Medici et al.
JOURNAL OF CELL BIOLOGY (2008)
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Rahul Kakkar et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Damo Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions
Liza J. Raggatt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
Hiroko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes
NHR Litjens et al.
CLINICAL IMMUNOLOGY (2006)
Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation
DL Andress
KIDNEY INTERNATIONAL (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Biomarkers of inflammation and progression of chronic kidney disease
M Tonelli et al.
KIDNEY INTERNATIONAL (2005)
Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis
CK Chiang et al.
BLOOD PURIFICATION (2005)
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
M Brunner et al.
INTENSIVE CARE MEDICINE (2004)
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction
M Shimpo et al.
CIRCULATION (2004)
Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients
C Libetta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients
U Sester et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
分享论文
